产品描述信息
NR-4057?? Peptide Arrays, HLA Supertype A and B Epitopes of Vaccinia Virus Proteins (Peptides and Peptide Arrays)|Vaccinia virus|Peptide Arrays, HLA Supertype A and B Epitopes of Vaccinia Virus Proteins |-20°C|NIH Biodefense and Emerging Infections Research Resources RepositoryAcknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH: Peptide Arrays, HLA Supertype A and B Epitopes of Vaccinia Virus Proteins, NR-4057."|Quantity Limit per Order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.NR-4057 contains six peptide arrays. The first peptide array (NRC-415; 12 peptides) consists of HLA supertype A1 epitopes of the vaccinia virus proteins: C19L, C10L, C10L, C12L, VWR050, D1R, D12L, B8R, B8R, B8R variant, B8R, and C19L. The second peptide array (NRC-416; 34 peptides) consists of HLA supertype A2 epitopes of the vaccinia virus proteins: C7L, N2L, F12L, F12L, VACWR082, E2L, E9L, O1L, I4L, A6L, D3R, A26L, A36R, A36R variant, A55R, A14L, I1L, A46R, A17L, H3L, B14R, B14R variant, A6L, D12L, G7L, VACWR050, M1L, A17L, B6R, VETFsm, A26L, A26L variant, B22R & C16L, and B22R & C16L variant. The third peptide array (NRC-417; 17 peptides) consists of HLA supertype A3 epitopes of the vaccinia virus proteins: C12L, C9L, C7L, C5L, I3L, G8R, J6R, D1R, D5R, D5R variant, A8R, A31R, A31R variant, A31R variant, B5R, B14R, and B14R variant. The fourth peptide array (NRC-418; 5 peptides) consists of HLA supertype A24 epitopes of the vaccinia virus proteins: D5R, D5R, D5R variant, C6L, and C6L variant. The fifth peptide array (NRC-419; 8 peptides) consists of HLA supertype B7 epitopes of the vaccinia virus proteins: C1L, C1L variant, F4L, F4L variant, O1L, J6R, D1R, and D1R variant. The sixth peptide array (NRC-420; 6 peptides) consists of HLA supertype B44 epitopes of the vaccinia virus proteins: C3L, C3L variant, C3L variant, G2R, G2R variant, and B8R. Peptides are 9- to 10-mers.Peptides are provided lyophilized at 1 mg per vial.